Nymbl Science, Inc. — Form D/A
Nymbl Science, Inc. of Denver, CO, a company, filed a Form D amendment with the SEC on 2019-08-01. The offering totals $2.7M, of which $2.3M was reported sold. Industry: Other Technology.
Offering
- Filed: 2019-08-01
- Form: D/A
- Accession: 0001781552-19-000004
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $2.7M
- Amount sold: $2.3M
- Remaining: $350K
- Minimum investment: $10K
- Investors: 27
- Date of first sale: 2019-06-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-344117
Issuer
- Name: Nymbl Science, Inc.
- CIK: 0001781552
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 2000 S Colorado Blvd, Denver, CO, 80222
- Phone: 650-233-4548
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| James Cook | Executive Officer | Issaquah, WA |
| Thomas Virden | Executive Officer | Denver, CO |
| Carol Owens Jones | Promoter | Denver, CO |
| Thomas Virden | Director | Denver, CO |
| Thomas Virden | Promoter | Denver, CO |
| Ben Wire | Director | Denver, CO |
| Edward Likovich | Director | Denver, CO |
| Edward Likovich | Executive Officer | Denver, CO |
| Edward Likovich | Promoter | Denver, CO |
| Chris Saxman | Director | Denver, CO |
| Rohit Seth | Director | Denver, CO |
| Meghan Oliver | Director | Denver, CO |
| David Eichler | Director | Denver, CO |
| James Cook | Director | Issaquah, WA |
| James Cook | Promoter | Issaquah, WA |
| Philip Linville | Director | Denver, CO |
| Caroline Owen-Jones | Promoter | Denver, CO |
| Dr. Jean-Pierre Farcy | Promoter | Denver, CO |
Other filings by this issuer (4)
More